Dipexium Pharmaceuticals, Inc. (DPRX) has 8 open-market insider trades by 7 insiders since 2014. The most active filer is Jack H. Dean, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jack H. Dean | Dir | — | 2 | $52K | 2014-05-21 |
| Christopher J. Coughlin | Dir | — | 1 | $25K | 2014-03-18 |
| Robert J. Deluccia | Chairman10% | — | 1 | $25K | 2014-03-18 |
| David Garrett | VPFinance & Corp. Dev. | — | 1 | $25K | 2014-03-18 |
| David P. Luci | CEOPresSecretary10% | — | 1 | $25K | 2014-03-18 |
| Thomas L. Harrison | Dir | — | 1 | $24K | 2014-03-18 |
| Robert G. Shawah | Chief Accounting Officer | — | 1 | $6K | 2014-03-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jack H. Dean | Director | Buy | $27K | 2014-05-21 |
| Christopher J. Coughlin | Director | Buy | $25K | 2014-03-18 |
| Thomas L. Harrison | Director | Buy | $24K | 2014-03-18 |
| Robert G. Shawah | Chief Accounting Officer | Buy | $6K | 2014-03-18 |
Companies that share insiders with DPRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.